© 2004 by Oxford University Press
© 2004 Oxford University Press
ARTICLE |
Effects of Reduced Cigarette Smoking on the Uptake of a Tobacco-Specific Lung Carcinogen
Affiliations of authors: Transdisciplinary Tobacco Use Research Center and College of Pharmacy, University of Minnesota, Minneapolis.
Correspondence to: Stephen S. Hecht, PhD, University of Minnesota Cancer Center, Mayo Mail Code 806, 420 Delaware St., SE, Minneapolis, MN 55455 (e-mail: hecht002{at}umn.edu)
Background: Limited data are available on carcinogen uptake in smokers who reduce their smoking. To determine whether reducing the number of cigarettes smoked per day would lead to a corresponding reduction in carcinogen uptake, we measured levels of metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of smokers who reduced their smoking for up to 26 weeks. Methods: We recruited 153 smokers, of whom 151 were randomly assigned to a reduction group or a waitlist group. In the reduction group of 102 smokers, we measured the metabolites 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) and its glucuronides (NNAL-Gluc) at two baseline times and at weeks 4, 6, 8, 12, and 26 after baseline. Smokers were then expected to reduce their number of cigarettes per day by 25% in weeks 0–2, 50% in weeks 2–4, and 75% in weeks 4–6 and to maintain the reduced level through week 26. In the waitlist group of 49 smokers, four baseline measurements over 7 weeks were made to assess the longitudinal stability of the metabolite measurements, and then the smokers began the reduction program. All statistical tests were two-sided. Results: For waitlist and reduction groups results were comparable. Statistically significant reductions in the lung carcinogen metabolites were observed at most intervals as smokers reduced the number of cigarettes smoked each day. However, the observed decreases were generally modest, always proportionally less than the reductions in cigarettes smoked per day, and sometimes transient. For example, among the 65 individuals in the reduction group who reduced cigarettes per day by 40% or more during weeks 4–12 after baseline, mean decreases in cigarettes per day were 53% (week 4), 74% (week 6), 75% (week 8), and 74% (week 12); whereas the corresponding mean reductions in NNAL plus NNAL-Gluc were 29%, 33%, 37%, and 29%. (P<.001 for all NNAL plus NNAL-Gluc values) Conclusions: Statistically significant reductions in levels of urinary metabolites of a tobacco-specific lung carcinogen were achieved by reduction in smoking, but for most smokers, reductions were modest and transient.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Smoking Reduction and Tobacco-Related Cancers: The More Things Change, the More They Stay the Same
- Scott J. Leischow and Mirjana V. Djordjevic
J Natl Cancer Inst 2004 96: 86-87.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  M. E. Mooney, Z.-z. Li, S. E. Murphy, P. R. Pentel, C. Le, and D. K. Hatsukami Stability of the Nicotine Metabolite Ratio in ad Libitum and Reducing Smokers Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1396 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, S. E. Murphy, W. T. Riley, C. Le, X. Luo, M. Mooney, and D. K. Hatsukami Similar Exposure to a Tobacco-Specific Carcinogen in Smokeless Tobacco Users and Cigarette Smokers Cancer Epidemiol. Biomarkers Prev., August 1, 2007; 16(8): 1567 - 1572. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hammond, F. Wiebel, L. T Kozlowski, R. Borland, K M. Cummings, R. J O'Connor, A. McNeill, G. N Connolly, D. Arnott, and G. T Fong Revising the machine smoking regime for cigarette emissions: implications for tobacco control policy Tob. Control, February 1, 2007; 16(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. K. Hatsukami, C. T. Le, Y. Zhang, A. M. Joseph, M. E. Mooney, S. G. Carmella, and S. S. Hecht Toxicant Exposure in Cigarette Reducers versus Light Smokers Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2355 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. A. Strasser, R. J. O'Connor, M. E. Mooney, and E. P. Wileyto Digital Image Analysis of Cigarette Filter Stains as an Indicator of Compensatory Smoking Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2565 - 2569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. O'Connor, G. A. Giovino, L. T. Kozlowski, S. Shiffman, A. Hyland, J. T. Bernert, R. S. Caraballo, and K. M. Cummings Changes in Nicotine Intake and Cigarette Use Over Time in Two Nationally Representative Cross-Sectional Samples of Smokers Am. J. Epidemiol., October 15, 2006; 164(8): 750 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, A. Yoder, M. Chen, Z.-z. Li, C. Le, R. Dayton, J. Jensen, and D. K. Hatsukami Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol. Biomarkers Prev., October 1, 2006; 15(10): 1805 - 1811. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Joseph, S. S. Hecht, S. E. Murphy, S. G. Carmella, C. T. Le, Y. Zhang, S. Han, and D. K. Hatsukami Relationships between Cigarette Consumption and Biomarkers of Tobacco Toxin Exposure Cancer Epidemiol. Biomarkers Prev., December 1, 2005; 14(12): 2963 - 2968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Hatsukami, M. Kotlyar, S. Allen, J. Jensen, S. Li, C. Le, and S. Murphy Effects of Cigarette Reduction on Cardiovascular Risk Factors and Subjective Measures Chest, October 1, 2005; 128(4): 2528 - 2537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Godtfredsen, E. Prescott, and M. Osler Effect of Smoking Reduction on Lung Cancer Risk JAMA, September 28, 2005; 294(12): 1505 - 1510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Simmons, J. E. Connett, M. A. Nides, P. G. Lindgren, E. C. Kleerup, R. P. Murray, W. M. Bjornson, and D. P. Tashkin Smoking reduction and the rate of decline in FEV1: results from the Lung Health Study Eur. Respir. J., June 1, 2005; 25(6): 1011 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Benowitz, P. Jacob III, J. T. Bernert, M. Wilson, L. Wang, F. Allen, and D. Dempsey Carcinogen Exposure during Short-term Switching from Regular to "Light" Cigarettes Cancer Epidemiol. Biomarkers Prev., June 1, 2005; 14(6): 1376 - 1383. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. S. Hecht Tobacco Carcinogen Biomarkers: Old and New Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 85 - 88. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. E. Murphy, S. G. Carmella, S. Li, J. Jensen, C. Le, A. M. Joseph, and D. K. Hatsukami Similar Uptake of Lung Carcinogens by Smokers of Regular, Light, and Ultralight Cigarettes Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 693 - 698. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Dunsby and L Bero A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes Tob. Control, December 1, 2004; 13(4): 362 - 369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. E. Murphy, C. A. Link, J. Jensen, C. Le, S. S. Puumala, S. S. Hecht, S. G. Carmella, L. Losey, and D. K. Hatsukami A Comparison of Urinary Biomarkers of Tobacco and Carcinogen Exposure in Smokers Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1617 - 1623. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. K. Hatsukami, C. Lemmonds, Y. Zhang, S. E. Murphy, C. Le, S. G. Carmella, and S. S. Hecht Evaluation of Carcinogen Exposure in People Who Used "Reduced Exposure" Tobacco Products J Natl Cancer Inst, June 2, 2004; 96(11): 844 - 852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, P. M.J. Kenney, S.-H. Low, K. Arakawa, and M. C. Yu Effects of Cruciferous Vegetable Consumption on Urinary Metabolites of the Tobacco-Specific Lung Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Singapore Chinese Cancer Epidemiol. Biomarkers Prev., June 1, 2004; 13(6): 997 - 1004. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Hecht, S. G. Carmella, K.-A. Le, S. E. Murphy, Y. S. Li, C. Le, J. Jensen, and D. K. Hatsukami Effects of Reduced Cigarette Smoking on Levels of 1-Hydroxypyrene in Urine Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 834 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Leischow and M. V. Djordjevic Smoking Reduction and Tobacco-Related Cancers: The More Things Change, the More They Stay the Same J Natl Cancer Inst, January 21, 2004; 96(2): 86 - 87. [Full Text] [PDF]
|
|